Patent Assignment
Reel/Frame 065708/0926
Assignment of Assignor's Interest
Recorded: 2023-11-29
Pages: 26
Assignor
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Executed: 2016-06-02
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BLVD, NEWARK, CALIFORNIA, 94560
Covered Property
(1)
Methods of Treating an Optic Disease in a Subject
Application:
18/521,777 →
Publication:
US 2024/0100135
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 29, 2023
From: BORODIC, GARY
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 065709/0020 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0663 →
Security Interest
Feb 7, 2025
From: REVANCE THERAPEUTICS, INC.; BELLUS MEDICAL, LLC; CROWN LABORATORIES, INC.
To: HAYFIN SERVICES LLP, AS ADMINISTRATIVE AGENT
Reel/Frame 070153/0736 →
Security Interest
Feb 17, 2025
From: REVANCE THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 070239/0739 →